Skip to content

King Pharmaceuticals KG Change in unearned premiums

Change in unearned premiums at other companies

Everest Group logo
Everest GroupEG
-$519M-241%
SiriusPoint logo
SiriusPointSPNT
$135.8M-23.5%
Skyward Specialty Insurance Group, Inc. logo
Skyward Specialty Insurance Group, Inc.SKWD
$34.21M+61.7%
W.R. Berkley logo
W.R. BerkleyWRB
$47.87M-57.7%
Universal Insurance Holdings logo
Universal Insurance HoldingsUVE
$7.88M-54.9%
Greenlight Capital RE, Ltd. logo
Greenlight Capital RE, Ltd.GLRE
$52.61M-12.0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInUnearnedPremiums.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's change in unearned premiums.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's change in unearned premiums?
King Pharmaceuticals (KG) reported change in unearned premiums of -$512K in Q1 2026.
What does change in unearned premiums mean?
The net change in the portion of written premiums that relates to the unexpired period of insurance policies. This metric represents the company's future service obligations and is a key indicator of premium growth trends. An increase typically suggests strong new business production, while a decrease may indicate a contraction in the insurance portfolio.